These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18323545)

  • 41. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
    Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
    J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure.
    Derenzini M; Donati G; Mazzini G; Montanaro L; Vici M; Ceccarelli C; Santini D; Taffurelli M; Treré D
    Clin Cancer Res; 2008 Apr; 14(7):2199-209. PubMed ID: 18381962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence.
    Fujimoto T; Nanjyo H; Fukuda J; Nakamura A; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
    Gynecol Oncol; 2009 Feb; 112(2):342-7. PubMed ID: 19062082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A study on the relationship between breast cancer molecular classification and prognosis].
    Chen XS; Ma CD; Chen CM
    Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1400-3. PubMed ID: 19094512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating epithelial tumor cells as a prognostic tool for malignant melanoma.
    Pachmann K; Willecke-Hochmuth R; Schneider K; Kaatz M
    Melanoma Res; 2018 Feb; 28(1):37-43. PubMed ID: 29076925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Role of palliative surgery in complex treatment for disseminated breast cancer].
    Orlova RV; Moiseenko VM; Gafton GI; Kochnev VA; Shchukin VV; Semiglazov VV; Raskin GA
    Vopr Onkol; 2007; 53(5):521-5. PubMed ID: 18154113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new predictive and prognostic marker (ATP bioluminescence and positron emission tomography) in vivo and in vitro for delivering adjuvant treatment plan to invasive breast tumor patients.
    Loo WT; Tong JM; Cheung MN; Chow LW
    Biomed Pharmacother; 2006 Jul; 60(6):285-8. PubMed ID: 16860527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
    De Maeyer L; Van Limbergen E; De Nys K; Moerman P; Pochet N; Hendrickx W; Wildiers H; Paridaens R; Smeets A; Christiaens MR; Vergote I; Leunen K; Amant F; Neven P
    J Clin Oncol; 2008 Jan; 26(2):335-6; author reply 336-8. PubMed ID: 18182677
    [No Abstract]   [Full Text] [Related]  

  • 51. Dynamics of circulating t(14;18)-positive cells during first-line and subsequent lines of treatment in follicular lymphoma.
    Mandigers CM; Meijerink JP; van 't Veer MB; Mensink EJ; Raemaekers JM
    Ann Hematol; 2003 Dec; 82(12):743-9. PubMed ID: 14513290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating tumor cells in breast cancer.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma.
    Dantonello TM; Int-Veen C; Winkler P; Leuschner I; Schuck A; Schmidt BF; Lochbuehler H; Kirsch S; Hallmen E; Veit-Friedrich I; Bielack SS; Niggli F; Kazanowska B; Ladenstein R; Wiebe T; Klingebiel T; Treuner J; Koscielniak E
    J Clin Oncol; 2008 Jan; 26(3):406-13. PubMed ID: 18202417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neoadjuvant systemic chemotherapy for patients with operable breast cancer].
    Zhang B; Zhang Q
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):161-5. PubMed ID: 17649628
    [No Abstract]   [Full Text] [Related]  

  • 55. NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup.
    Retsky M; Rogers R; Demicheli R; Hrushesky WJ; Gukas I; Vaidya JS; Baum M; Forget P; Dekock M; Pachmann K
    Breast Cancer Res Treat; 2012 Jul; 134(2):881-8. PubMed ID: 22622810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients.
    Hauch S; Zimmermann S; Lankiewicz S; Zieglschmid V; Böcher O; Albert WH
    Anticancer Res; 2007; 27(3A):1337-41. PubMed ID: 17593628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer.
    Hartkopf AD; Wagner P; Wallwiener D; Fehm T; Rothmund R
    Anticancer Res; 2011 Mar; 31(3):979-84. PubMed ID: 21498725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Migrating and circulating breast carcinoma cells are within active phases of the cell cycle.
    Kubens BS; Feldner JC; Brandt B; Zänker KS
    Anticancer Res; 2002; 22(2A):899-903. PubMed ID: 12014669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of adjuvant radiotherapy on circulating epithelial tumor cells and circulating cancer stem cells in primary non-metastatic breast cancer.
    Schott DS; Pizon M; Pachmann U; Pachmann K; Schobert R; Wittig A; Mäurer M
    Transl Oncol; 2021 Mar; 14(3):101009. PubMed ID: 33453469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Problems with the progesterone receptor in practice?
    Jordan VC; Gelber RD
    J Clin Oncol; 2007 May; 25(15):1957-9. PubMed ID: 17452674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.